Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda

Table 4 Factors associated with mixed MTB infection among MDR/RR-TB patients

Variable		Participants (n/%) N = 53	Frequency (n)	Positive for Mixed TB infection n (%) N = 5	Unadjusted* OR (95% CI)	P-Values
MDR	No	54.8	23	2/23 (8.7)	1.071 (0.103–11.130)	0.954
MDR	Yes	45.2	30	3/30 (10.0)	1.071 (0.103–11.130)	0.954
XPT test results	RR D	92.9	48	3/48 (6.3)	24.00 (1.66–347.89)	0.033*
XPT test results	RR ND	7.1	5	2/5 (40.0)	24.00 (1.66–347.89)	0.033*
HIV	Negative	61.9	37	1/37 (2.7)	8.333 (0.84–82.86)	0.040*
HIV	Positive	38.1	16	4/16 (25.0)	8.333 (0.84–82.86)	0.040*

RR Rifampicin Resistance: ND Not Detected: D Detected: XPT Xpert MTB/RIF: MDR Multi-Drug Resistant: OR Odds Ratio: CI Confidence Interval: *few variables for adjusted OR

ISSN: 1471-2334